Chief Medical Officer of the Danish Medicines Agency appointed new member of the EU Pharmacovigilance Working Party

Torbjörn Callréus, Chief Medical Officer of the Danish Medicines Agency’s Consumer Safety Division has been appointed co-opted expert for the European Medicines Agency's Pharmacovigilance Working Party, PhVWP.

Doctor Torbjörn Callréus specialises in Clinical Pharmacology and obtained his PhD from Lund University in Sweden. His research in recent years has been particularly dedicated to the study of the use and effects of drugs in large groups of people, referred to as pharmacoepidemiology. He has been elected for a term of three years with the possibility of re-election.

You can find the summaries from the monthly meetings of the EU Pharmacovigilance Working Party (PhVWP) in the factbox to the right.

Danish Medicines Agency, 2 March 2010